rofecoxib has been researched along with Dysmenorrhea in 11 studies
Dysmenorrhea: Painful menstruation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea." | 9.10 | Dysmenorrhea treatment with a single daily dose of rofecoxib. ( Kurban, Y; Sahin, I; Saraçoğlu, F; Türkkani, B, 2003) |
| "To determine whether rofecoxib is effective for treating primary dysmenorrhea and whether cyclooxygenase-2 is involved in the pathophysiology of primary dysmenorrhea." | 9.09 | Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. ( Cantu, N; Daniels, SE; Kotey, P; Morrison, BW; Seidenberg, B, 1999) |
| "Rofecoxib and diclofenac potassium, when taken in recommended doses, were equally effective in alleviating pain associated with primary dysmenorrhea." | 5.13 | The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain. ( Chantler, I; Fuller, A; Mitchell, D, 2008) |
| "To investigate the efficacy of single daily doses of rofecoxib, a selective inhibitor of cyclooxygenase-2, in dysmenorrhea." | 5.10 | Dysmenorrhea treatment with a single daily dose of rofecoxib. ( Kurban, Y; Sahin, I; Saraçoğlu, F; Türkkani, B, 2003) |
| "To determine whether rofecoxib is effective for treating primary dysmenorrhea and whether cyclooxygenase-2 is involved in the pathophysiology of primary dysmenorrhea." | 5.09 | Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. ( Cantu, N; Daniels, SE; Kotey, P; Morrison, BW; Seidenberg, B, 1999) |
| "Rofecoxib, used for dysmenorrhea, caused a herpetiform fixed drug eruption predominantly involving the lips with classic clinical and histological findings in a red-brown lesion on the dorsal hand." | 3.71 | Fixed drug eruption to rofecoxib. ( Florentino, FT; Gilliam, AC; Nedorost, ST, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 8 (72.73) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nedorost, ST | 1 |
| Florentino, FT | 1 |
| Gilliam, AC | 1 |
| Sahin, I | 1 |
| Saraçoğlu, F | 1 |
| Kurban, Y | 1 |
| Türkkani, B | 1 |
| Bitner, M | 1 |
| Kattenhorn, J | 1 |
| Hatfield, C | 1 |
| Gao, J | 1 |
| Kellstein, D | 1 |
| Yodfat, Y | 1 |
| Chantler, I | 1 |
| Mitchell, D | 1 |
| Fuller, A | 1 |
| Scott, LJ | 1 |
| Lamb, HM | 1 |
| Morrison, BW | 1 |
| Daniels, SE | 1 |
| Kotey, P | 1 |
| Cantu, N | 1 |
| Seidenberg, B | 1 |
| Miller, JL | 1 |
| Sirakov, M | 1 |
| FitzGerald, GA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Effect of a Vaginal Ring With Meloxicam on Primary Dysmenorrhea in Women of Childbearing Age[NCT02255045] | Phase 2/Phase 3 | 68 participants (Actual) | Interventional | 2014-06-27 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for rofecoxib and Dysmenorrhea
| Article | Year |
|---|---|
[Is there a future for COX-2 inhibitors?].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase 2; Cyclooxygenase 2 I | 2004 |
Rofecoxib.
Topics: Analgesics; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug Interactions; Dysmenorrhea; En | 1999 |
[VIOXX--a new world without pain].
Topics: Adult; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Lactones; Pain; Sulfones | 2001 |
4 trials available for rofecoxib and Dysmenorrhea
| Article | Year |
|---|---|
Dysmenorrhea treatment with a single daily dose of rofecoxib.
Topics: Administration, Oral; Adult; Analysis of Variance; Chi-Square Distribution; Cross-Over Studies; Cycl | 2003 |
Efficacy and tolerability of lumiracoxib in the treatment of primary dysmenorrhoea.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase | 2004 |
The effect of three cyclo-oxygenase inhibitors on intensity of primary dysmenorrheic pain.
Topics: Adult; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationshi | 2008 |
Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Lactones; Pain; Sulfones | 1999 |
4 other studies available for rofecoxib and Dysmenorrhea
| Article | Year |
|---|---|
Fixed drug eruption to rofecoxib.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Dysmenorrhea; Erythema; Female; Huma | 2002 |
Second selective COX-2 inhibitor receives marketing approval.
Topics: Clinical Trials as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; | 1999 |
Nonsteroidal anti-inflammatory drugs, coxibs, and cardio-renal physiology: a mechanism-based approach.
Topics: Adenomatous Polyposis Coli; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Cardiovascular Syste | 2002 |
[New indication for selective COX-2 inhibitors. Now also approve for acute pain].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Drug A | 2002 |